The role of epidermal growth factor receptor (EGFR) in the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer patients

Background. Identification of predictive molecular markers of triple-negative breast cancer (TNBC) will enable the evaluation of the efficacy of neoadjuvant chemotherapy (NACT) and define optimum approaches for the prognosis of the disease course in TNBC patients.The aim of the study was to examine...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: N. N. Babyshkina, T. A. Dronova, E. A. Zambalova, M. V. Zavyalova, E. M. Slonimskaya, N. V. Cherdyntseva
Format: Artigo
Sprog:Inglês
Udgivet: Siberian State Medical University (Tomsk) 2020-04-01
Serier:Bûlleten' Sibirskoj Mediciny
Fag:
triple-negative breast cancer
neoadjuvant chemotherapy
epidermal growth factor receptor (egfr)
gene polymorphisms
Online adgang:https://bulletin.tomsk.ru/jour/article/view/2675
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker